The Venture Codex Logo

The Venture Codex

Panther Group

3280 Peachtree Rd, 7th Floor, Atlanta, GA, 30329, United States

Overview

The Panther Group is a cannabis venture capital advisory firm, operating since 2014, with a vetted marketplace of cannabis investment deals along with an extensive network of tens of thousands of cannabis professionals and investors that span across more than 20 sectors of the cannabis industry.

Total investments
2
Lead investments
0
Investments · 12mo
0
Active investors
1
Visit website

Investment portfolio

  • Genetica

    Participated · Equity · Nov 2023

    Genetica develops AI-driven retail solutions for the cannabis market, including its Flora Match product for retailers and brands and Flora OS, currently in beta. The company reports rapid adoption with over 300 clients globally and 280% month-over-month growth. Genetica is on pace to deploy its software to north of 2,500 locations by the end of 2024. The team plans to use the recent funding to expand in U.S. and European markets and to grow headcount over the next quarter. Its product suite focuses on improving consumer education, increasing basket sizes, and delivering deep consumer insights for brands. Genetica is an AI-powered cannabis retail platform founded in 2020 and based in San Francesco, CA, led by CEO Ben York. Its core product is Flora AI, which analyzes over 650 million data points to deliver precise product recommendations. The flagship offering, Flora Match, personalizes recommendations using in-store inventory, customers’ dietary habits, activity levels, age, medical conditions, and desired effects, complementing store employees and enabling upselling. The product suite is set to expand later this year with Flora OS, an all-in-one operating system using AI to optimize retail operations. The company intends to use the $500K seed funds to expand into more dispensaries nationwide and into other retailers such as grocery stores and pharmacies. It is on pace to launch its software into more than 350 U.S. locations and dozens of retail and pharmacy entities over the next quarter.

  • Willow Industries

    Participated · Series A · Feb 2022

    Willow Industries develops WillowPure, a patented, organic ozone-based post-harvest microbial decontamination technology for cannabis. The technology is scientifically proven to reduce or eliminate contaminants such as yeast, mold and bacteria while protecting the plant's medicinal properties. Willow focuses on providing cultivators with a kill-step solution to deliver clean, high-quality products to patients and consumers. Its WillowPure system is currently deployed in 26 U.S. states. The company has begun international expansion into Canada and Australia. Willow intends to use the new funds to accelerate its international growth. Willow Industries builds the patent-pending WillowPure ozone systems to remove microbial contaminants from harvested cannabis while preserving terpenes, potency, color and taste. The technology uses industry-recognized USDA/EPA approved ozone gas and is described as environmentally friendly, non-toxic, and scalable. Willow has deployed WillowPure in three volume-scaled, mobile units to serve boutique cultivators through large multi-state operators and currently operates in nine states. The company says its solution has saved cultivators over $50M in flower failure. Willow positions its product around consumer safety and helping cultivators sell clean, high-quality cannabis, and expects to scale and expand alongside the legal cannabis industry domestically and internationally.

Team